EXELIXIS INC (EXEL:NASDAQ)
$59.86 0.84 (1.4232%)
Analysed EXELIXIS INC (EXEL:NASDAQ) News Sources
Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay
11-09-2026
yahoo.com
EXEL Stock Slides After FDA Adds Three Months To Cancer Drug Review — William Blair Sees More Swings In Near Term
11-09-2026
stocktwits.com
Exelixis Eyes CABOMETYX Growth, Zanzalintinib Catalysts Across Cancer Franchises
14-09-2026
marketbeat.com
Exelixis Eyes Zanza Launch as CABOMETYX Growth Faces NET Ramp Hurdle
15-09-2026
marketbeat.com
Exelixis (EXEL) Faces a Three-Month Zanzalintinib Review Extension. Can the Data Support Approval?
17-09-2026
yahoo.com
Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans?
24-09-2026
yahoo.com
Exelixis Shares Rising on CABOMETYX Revenue
30-09-2026
yahoo.com
Is Exelixis Stock Engineered To Make You Money?
07-10-2026
trefis.com
Exelixis (EXEL) Stock May Be Undervalued As Earnings Stay In Focus
08-10-2026
yahoo.com
Is Exelixis (EXEL) Fully Valued As Its Cabozantinib Patent Window Comes Into Focus?
08-10-2026
yahoo.com
What is the current price of EXELIXIS INC (EXEL:NASDAQ)?
The current price of EXELIXIS INC (EXEL:NASDAQ) is $59.86.
EXELIXIS INC (EXEL:NASDAQ) absolute price change since previous trading day?
The absolute price change of EXELIXIS INC (EXEL:NASDAQ) since the previous trading day is $0.84.
EXELIXIS INC (EXEL:NASDAQ) percentage price change since previous trading day?
The percentage price change of EXELIXIS INC (EXEL:NASDAQ) since the previous trading day is 1.4232%.
What is the most recent average sentiment score for EXELIXIS INC (EXEL:NASDAQ)?
The most recent average sentiment score for EXELIXIS INC (EXEL:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for EXELIXIS INC (EXEL:NASDAQ)?
The most recent sentiment for EXELIXIS INC (EXEL:NASDAQ) is .
SEC-8K** Filing Available For EXELIXIS INC (EXEL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.